Markets

Stocks To Watch: Idexx Laboratories Sees RS Rating Jump To 83

Shutterstock photo

The Relative Strength ( RS ) Rating for Idexx Laboratories ( IDXX ) entered a new percentile Wednesday, with a rise from 80 to 83.

[ibd-display-video id=2102289 width=50 float=left autostart=true] IBD's unique rating identifies market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the trailing 52 weeks stacks up against all the other stocks in our database.

Decades of market research reveals that the market's biggest winners often have an 80 or better RS Rating in the early stages of their moves.

Looking For Winning Stocks? Try This Simple Routine

Idexx Laboratories is working on a flat base with a 173.11 buy point . See if the stock can break out in volume at least 40% above average.

Earnings growth decreased in the most recent report from 28% to 16%. But revenue moved higher, from 9% to 10%.

The company holds the No. 5 rank among its peers in the Medical-Systems/Equipment industry group. Cantel Medical ( CMD ) is the No. 1-ranked stock within the group.

RELATED:

Stocks With Rising Relative Strength Ratings

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

RS CMD IDXX

Other Topics

Stocks